Sentences with phrase «clinical oncology research»

ASCO's growing roster of cutting - edge journals serves readers as the most credible, authoritative, peer - reviewed resources for significant clinical oncology research and research that informs the delivery of efficient, high - quality cancer care across the globe.
Academic & Student Affairs Center for One Health Illinois Clinical Skills Learning Center College of Veterinary Medicine Facilities Fund Companion Animal Dermatology Resident Training Companion Animal Memorial Fund Conservation Medicine Endowment Dermatology Research Fund Equine Research Farm Animal Medicine, Reproduction & Surgery Friends of ER / ICU Fund Friends of Shelter Medicine Holistic Medicine Fund Humane Society Dental Program Fund Integrated Food Animal Medicine System Program Fund Research in Veterinary Medicine Small Animal Surgery Fund Stafford Clark - Price Memorial Feline Compassion Award VCM Dental Laboratory Fund VCM Magrane Comparative Opthalmology Fund VCM Seminar Series VCM Study Abroad Program Veterinary Continuing Education and Public Service Extension Programs Veterinary Heritage Collection and Information Commons Veterinary Medical Alumni Association Fund Veterinary Medicine Achievement Fund VM Clinical Oncology Research Fund VM Surgical Oncology Unrestricted Fund Wildlife Medical Clinic
These include studies that are sponsored by the Eastern Cooperative Oncology Group (ECOG), the Gynecologic Oncology Group, the AIDS Malignancy Consortium and Accelerated Clinical Oncology Research Network (ACORN).
In addition, University of Chicago doctors hold leadership positions in two national cooperative clinical oncology research groups — the American College of Surgeons Oncology Group (ACOSOG) and the Alliance for Clinical Trials in Oncology.
Connecting a global network of more than 40,000 cancer professionals, the society serves as the leading resource for best practices in clinical oncology research and academic and community practices.

Not exact matches

In a statement released Tuesday, the American Society of Clinical Oncology outlined research tying alcohol to two types of cancer and told Americans to drink less.
Participants included CEOs Jonathan Bush of Athenahealth, Ron Gutman of HealthTap, Dr. Clifford Hudis of the American Society of Clinical Oncology, Dr. Vivian Lee of University of Utah Health Care, VitalConnect CEO Nersi Nazari, James Park of Fitbit, and Andrew Witty of GSK, as well as President of Flex Health Solutions John Carlson, Multiple Myeloma Research Foundation Founder Kathy Giusti, Dr. Sanjay Gupta, Arianna Huffington, Andreessen Horowitz General Partner Vijay Pande, Parker Foundation President Sean Parker, Women's Alzheimer's Movement Founder Maria Shriver, and White House Cancer Moonshot Task Force Executive Director Greg Simon.
Dr. Larry Garbo and RN Amy Zuchelkowski of New York Oncology Hematology join Medical Monday to discuss clinical research.
We have estimated that up to 15 percent of patients will be candidates for dose optimization,» explained senior study author Javier F.Torres - Roca, MD, director of Clinical Research and associate member of the Department of Radiation Oncology at Moffitt.
Publishing April 4 in the Journal of Clinical Oncology, the research team compared the shortened radiation therapy schedule of about 5.5 weeks to the standard 8 - week regimen to determine if rates of cure were similar.
Clinical specialties that could fit that research interest include neurology, child neurology, neurodevelopmental disabilities, psychiatry, neuropathology, radiation oncology, neurosurgery, child psychiatry, and so on.
People diagnosed with cancer gained 3.34 million years of life thanks to cancer clinical trials run by SWOG and supported with public funds, according to new study results to be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research clinical trials run by SWOG and supported with public funds, according to new study results to be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research Clinical Oncology (ASCO), the world's largest clinical cancer research clinical cancer research meeting.
Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Mresearch are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal MResearch and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal MResearch and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;
Especially in a field like oncology, it's so important to be able to keep up with the current research, not just clinical but also the basic research,» she says.
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.
«This work is an example of how integrating basic science and clinical care may reveal privileged opportunities for biomedical research,» said Matthew O. Hebb, M.D., Ph.D., FRCSC, a researcher involved in the work from the Departments of Clinical Neurological Sciences (Neurosurgery), Oncology and Otolaryngology at the University of Western Ontario in Ontario,clinical care may reveal privileged opportunities for biomedical research,» said Matthew O. Hebb, M.D., Ph.D., FRCSC, a researcher involved in the work from the Departments of Clinical Neurological Sciences (Neurosurgery), Oncology and Otolaryngology at the University of Western Ontario in Ontario,Clinical Neurological Sciences (Neurosurgery), Oncology and Otolaryngology at the University of Western Ontario in Ontario, Canada.
New research presented at the American Society of Clinical Oncology (ASCO) 53rd Annual Meeting in Chicago shows that a previously untested combination of a monoclonal antibody - drug conjugate with a common chemotherapy agent has a high complete - response rate in children and young adults with relapsed or refractory Hodgkin lymphoma.
Principal investigator E. Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute and vice chair of research in the Duke University Department of Surgery, will lead the study through the cooperative group, The Alliance for Clinical Trials in Oncology.
«While e-cigarettes may reduce smoking rates and attendant adverse health risks, we will not know for sure until these products are researched and regulated,» said Peter Paul Yu, president of the 35,000 - member American Society of Clinical Oncology, in a statement.
The University of Sheffield's Department of Oncology and Metabolism conducts world - class research from basic clinical and translational cancer research to life course research and basic level biology through to diseases such as diabetes and osteoporosis.
However, what our trial has shown is that although this is still the case, the proportion of women who will actually have a recurrence without radiotherapy is very small (less than 5 percent), five years after treatment,» said Ian Kunkler, F.R.C.R., professor of clinical oncology at the Edinburgh Cancer Research Center in the University of Edinburgh.
After completing their specialty clinical training (e.g., in medicine or pediatrics), most physician - scientists pursue subspecialty clinical training (e.g., cardiology or hematology - oncology) and postdoctoral research that typically combines protected research time with intensive clinical training.
Research presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 used a newly designed test for K: B fusion to show that point mutations lead to a more dangerous form of the disease than does K: B fusion.
«Similarly 71 drugs approved by the FDA from 2002 to 2014 for solid tumours have resulted in median gains in progression - free and overall survival of only 2.5 and 2.1 months, respectively,» he says adding, «Also, only 42 per cent met the American Society of Clinical Oncology Cancer Research Committee's criteria for meaningful results for patients.»
As a first - year hematology - oncology fellow at Dana - Farber / Partners CancerCare 10 years ago, Catherine Wu recognized that if she wanted to bridge research and clinical practice, she needed to understand her options.
Professor Tim Maughan, Clinical Director of the Cancer Research UK / Medical Research Council Oxford Institute for Radiation Oncology, said «This novel and exciting finding provides a new scientific basis for precision targeting of some cancers which are currently very difficult to treat, and we are now taking these findings into clinical trialsClinical Director of the Cancer Research UK / Medical Research Council Oxford Institute for Radiation Oncology, said «This novel and exciting finding provides a new scientific basis for precision targeting of some cancers which are currently very difficult to treat, and we are now taking these findings into clinical trialsclinical trials.»
Reporting in the Journal of Clinical Investigation Insights, a team led by senior author Andrea Facciabene, PhD, a research assistant professor of Radiation Oncology and Obstetrics / Gynecology, found that the effectiveness of adoptive T cell therapy (ACT) in mice with cancer is significantly affected by differences in the natural makeup of gut bacteria and treatment with antibiotics.
Barrett, who directed NCI's Center for Cancer Research while Stevenson was a postdoc there, appointed her as Novartis's associate director of clinical research for oncology bioResearch while Stevenson was a postdoc there, appointed her as Novartis's associate director of clinical research for oncology bioresearch for oncology biomarkers.
New research on innovative immunotherapies for advanced or high - risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO).
The research is being presented today at the 2016 American Society of Clinical Oncology annual meeting in Chicago.
Research published in the Journal of Clinical Oncology indicates that adding trastuzumab to carboplatin - paclitaxel chemotherapy (CT) increased progression - free survival in patients with advanced or recurrent uterine serous carcinoma who overexpressed HER2 / neu.
«We hope that this will enable us to better understand and fight infectious diseases as well as bone marrow diseases such as leukemia,» says Carsten Riether from the Department of Clinical Research at the University of Bern and the Department of Medical Oncology at Bern University Hospital and the University of Bern.
The American Society of Clinical Oncology (ASCO) applauds Congress for its bipartisan support of the omnibus spending bill that significantly boosts our nation's investment in biomedical research.
Purpose: The development of the UNC Immuno - Oncology Patient Centered Translational Research (IMPACT) Biorepository involves the collection of tumor tissue and blood, as well as data (e.g., demographic, clinical, questionnaire) from patients attending Oncology Clinics at UNC Hospital and undergoing immune therapy through participation in a Merck IT trial at UNC.
The Department of Translational Hematology and Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patieResearch (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patieresearch to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
Pedro de Noronha Pissarra, chief executive officer of Biotecnol said: «We're very proud to work with Cancer Research UK on the development of advanced clinical trial approaches in this competitive and highly promising field of immuno - oncology.
St. Jude experts present pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Ooncology and survivorship research at the annual meeting of the American Society of Clinical OncologyOncology.
Dr. Jennifer S. Temel, clinical director of thoracic oncology at Massachusetts General Hospital, alluded to the emerging research on immunotherapy in a presentation to palliative care and hospice clinicians in February.
The study results were published online June 1 by the journal Breast Cancer Research and Treatment, and were presented June 4 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Oncology research and clinical advancements often require financial partnerships and collaborations between industry and oncology physicians and reseOncology research and clinical advancements often require financial partnerships and collaborations between industry and oncology physicians and reseoncology physicians and researchers.
She is a former member the editorial board of the Journal of Clinical Oncology, is currently on the editorial board of Cancer Research and the Breast Journal.
For more information, contact Kelly Jenkins, oncology clinical research nurse at the Georgia Cancer Center, at 706-721-1206.
The Endocrine Tumor Surgery setion within the Surgical Oncology department treats endocrine tumors in children and adults, with the goal of improving patient care through emerging technologies and advances in clinical and basic research.
This booklet explains how JAX ® Mice, Clinical and Research Services for oncology are essential tools for the in vivo study of...
Eliminating bias and accelerating the clinical translation of oral microbiome research in oral oncology — Rohit Kunnath Menon — Oral oncology — Rohit Kunnath Menon — Oral OncologyOncology
This booklet explains how JAX ® Mice, Clinical and Research Services for oncology are essential tools for the in vivo study of hematological malignancies, neoplasia, regenerative medicine, and immune - oncology.
As one of the finest pediatric hematology - oncology fellowship programs in the nation, our centers are training fellows to obtain outstanding clinical and laboratory research knowledge, paving the future of pediatric cancer and blood disorder care.
Continue to build clinical research programs in smoking cessation, genetic counseling and testing for hereditary cancer susceptibility and psychosocial oncology
He led Daiichi Sankyo's international research unit focused on early oncology therapeutic programs, strategy and development, and was accountable for development activities from post-target identification basic science research to first - in - man trials and proof - of - clinical concept.
Her main research interests are in the area of clinical health psychology and women's health and her work focuses on the psychological understanding and development of interventions for people with physical and emotional problems, in the areas of women's health (PMS and menopause), cardiology and oncology.
a b c d e f g h i j k l m n o p q r s t u v w x y z